Arnst Thomas W 4
4 · TENET HEALTHCARE CORP · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Tenet Healthcare EVP Thomas Arnst Receives Performance Award
What Happened
Thomas W. Arnst, EVP, Chief Administrative Officer & General Counsel of Tenet Healthcare Corporation (THC), was granted/acquired 37,785 shares of performance-based restricted stock on February 13, 2026. The Form 4 reports an acquisition at $0.00 (code A — award/grant); the filing lists $0 because these shares were awarded, not purchased. The award was earned when the company’s Human Resources Committee certified achievement of the applicable performance targets for the January 1, 2023 – December 31, 2025 performance period.
Key Details
- Transaction date: 2026-02-13; Form 4 filed: 2026-02-17. Filing appears timely.
- Transaction type/code: A — Award/Grant of restricted stock.
- Shares acquired: 37,785; reported acquisition price: $0.00 (award, not an open-market purchase).
- Shares owned after transaction: not specified in the provided filing.
- Footnote: F1 — the award represents performance-based restricted stock earned upon certification that the performance goals for the 2023–2025 period were met.
Context
Performance-based restricted stock is compensation tied to specific performance targets; these shares were earned and delivered upon certification rather than bought on the open market. Such grants are common executive compensation and do not, by themselves, indicate the insider is buying or selling stock for investment reasons.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-13+37,785→ 37,785 total
Footnotes (1)
- [F1]Represents a grant of performance-based restricted stock that was earned on the date the Human Resources Committee of the Company certified the achievement of the applicable performance targets based on the extent to which the applicable performance goals were attained for the performance period of January 1, 2023 to December 31, 2025.